Hemoglobinopathy Newborn Screening Test in UAE | 100 AED | DHA Licensed

Executive Summary & Core Metrics

Diagnostic Accuracy: 99.9% sensitivity for common hemoglobin variants via ISO-validated capillary electrophoresis.
Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
Clinical Support: Free telephonic result interpretation and seamless specialist referral coordination.
Insurance & Payment: Direct coverage verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

This newborn screening test detects genetic hemoglobin disorders such as sickle cell disease and thalassemia. A single heel prick blood sample is collected on a filter paper card and analyzed using capillary electrophoresis (CE), a fully automated, high-resolution method. The test is an essential first step in early diagnosis and management.

Feature	Our Test (Capillary Electrophoresis)	Closest Alternative (HPLC)
Methodology	Capillary Electrophoresis (CE) – fully automated, high-resolution	High-Performance Liquid Chromatography (HPLC)
Diagnostic Precision	99.9% sensitivity for common Hb variants; ISO-validated	Variable sensitivity; may miss rare variants
Turnaround Time	Next working day after Mon/Wed/Fri 9 AM cutoff	Often 2–3 days or longer
Sample Collection	1 drop heel prick on filter paper; VIP home collection available	Typically requires venipuncture or lab visit

Physician Insight & Safety Protocols

Dr. Ajay Singh (DHA Registration ID: 36234132), General Practitioner, notes:

“Newborn screening for hemoglobinopathies is a critical public health measure. A positive screening result does not confirm disease; it indicates the need for follow-up diagnostic testing and clinical evaluation. My team is committed to guiding parents through every step, providing clear interpretation and prompt specialist referrals when needed.”

⚠️ Important Advisory

If your infant shows any acute symptoms such as severe pallor, jaundice, respiratory distress, fever above 38°C, or extreme lethargy, do not rely on this screening result—seek emergency care immediately. A screening test is not a substitute for urgent medical attention.

Exclusion Criteria & ER Red Flags

This screen is for population-based newborn screening; it is not a diagnostic test. Confirmatory hemoglobin electrophoresis and/or genetic testing is mandatory for clinical decisions.
Do not rely solely on this result if the infant exhibits acute symptoms: severe pallor, jaundice, respiratory distress, fever >38°C, or extreme lethargy – seek emergency care immediately.
Infants with a known family history of severe hemoglobinopathy or those already under hematology care may require direct diagnostic testing rather than screening.
Contraindicated if the infant has received a blood transfusion within the last 3 months; the test may reflect donor hemoglobin.

Patient FAQ & Clinical Guidance

1. What does the hemoglobinopathy newborn screening test check?

This screening detects abnormal hemoglobin variants, including sickle cell disease and beta-thalassemia, using a newborn heel prick. It is a first step to identify infants who may need further testing.

2. Is the test painful for my baby?

The heel prick is quick and minimally painful, comparable to a routine blood glucose test in adults. Most infants tolerate it very well.

3. How quickly will I receive my baby’s screening results?

If the sample is collected on Monday, Wednesday, or Friday by 9 AM, the report is delivered electronically via a secure portal by the next working day. Home collection is available daily from 8 AM to 11 PM.

UAE Regulatory & Data Privacy Adherence

Trust & Compliance

This service is fully compliant with:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
Federal Law No. 2 of 2019 Concerning the Use of ICT in Health Fields
Federal Decree-Law No. 4 of 2016 on Medical Liability

ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA/MOHAP licensed facility. All data is encrypted and handled in accordance with UAE data protection regulations.

24/7 Support & Bookings: WhatsApp +971 54 548 8731

Clinical & Logistical Metadata

Test Name	Hemoglobinopathy Newborn Screening
Price (AED)	100
Turnaround Time	Next working day after Mon/Wed/Fri 9 AM cutoff; home collection daily 8 AM–11 PM
Sample Type / Matrix	Neonatal dried blood spot (heel prick)
Methodology Used	Capillary Electrophoresis (CE)
ICD-10-CM Code	Z13.0 (Encounter for screening for nutritional, metabolic and endocrine disorders), D57.0, D56.0
LOINC Code	51955-4 (Hemoglobin electrophoresis panel in Blood)
DHA Facility License & Address	DHA License #1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE